Life ScienceCompany
Point Biopharma Global Ownership
Who owns Point Biopharma Global?
Point Biopharma Global is owned by Eli Lilly. It was acquired on December 18, 2023.
Point Biopharma Global Business Overview
Where is Point Biopharma Global headquartered?
Point Biopharma Global is headquartered in Indianapolis, Indiana.
How many employees does Point Biopharma Global have?
Point Biopharma Global has 129 employees.
What sector is Point Biopharma Global in?
Point Biopharma Global is a life science company.
Life Science M&A Summary in 2023
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.
Join Mergr to view all 204 acquisitions of life science companies in 2023, including 26 acquisitions by private equity firms, and 178 by strategics.